159 related articles for article (PubMed ID: 24628251)
21. Carotid sparing hypofractionated tomotherapy in early glottic cancers: Refining image guided IMRT to improve morbidity.
Chatterjee S; Guha S; Prasath S; Mallick I; Achari R
J Cancer Res Ther; 2013; 9(3):452-5. PubMed ID: 24125982
[TBL] [Abstract][Full Text] [Related]
22. The results of radiotherapy for T1 glottic cancers; influence of radiation beam energy.
Yamamoto M; Joja I; Takemoto M; Kuroda M; Hiraki Y
Acta Med Okayama; 1999 Apr; 53(2):91-4. PubMed ID: 10358724
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
24. Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer.
Kim YS; Lee J; Park JI; Sung W; Lee SM; Kim GE
Radiat Oncol J; 2016 Mar; 34(1):18-25. PubMed ID: 27104163
[TBL] [Abstract][Full Text] [Related]
25. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
26. Volumetric modulated arc therapy with robust optimization for larynx cancer.
Miura H; Doi Y; Ozawa S; Nakao M; Ohnishi K; Kenjo M; Nagata Y
Phys Med; 2019 Feb; 58():54-58. PubMed ID: 30824150
[TBL] [Abstract][Full Text] [Related]
27. Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.
Bahig H; Nguyen-Tan PF; Filion É; Roberge D; Thanomsack P; de Guise J; Blais D; Doucet R; Létourneau-Guillon L; Lambert L
J Med Imaging Radiat Oncol; 2017 Oct; 61(5):666-673. PubMed ID: 28557310
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of underdosage in the external photon beam radiotherapy of glottic carcinoma: Monte Carlo study.
Spirydovich S; Papiez L; Moskvin V; Desrosiers P
Radiother Oncol; 2006 Feb; 78(2):159-64. PubMed ID: 16360226
[TBL] [Abstract][Full Text] [Related]
29. Accelerated radiotherapy for T1 to T2 glottic cancer.
Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
[TBL] [Abstract][Full Text] [Related]
30. Minimising carotid artery dose in the radiotherapy of early glottic cancer.
Hardie CL; McKenna A; Przeslak AJ; Morgan DA
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):800. PubMed ID: 17764915
[No Abstract] [Full Text] [Related]
31. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.
Hong CS; Oh D; Ju SG; Ahn YC; Noh JM; Chung K; Kim JS; Suh TS
Cancer Res Treat; 2016 Jan; 48(1):63-70. PubMed ID: 25761477
[TBL] [Abstract][Full Text] [Related]
32. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
33. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
34. Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy.
Gupta A; Wong KH; Newbold K; Bhide S; Nutting C; Harrington KJ
Front Oncol; 2021; 11():753908. PubMed ID: 34616688
[TBL] [Abstract][Full Text] [Related]
35. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure.
Nozaki M; Furuta M; Murakami Y; Izawa Y; Iwasaki N; Takahashi H; Watanabe K
Anticancer Res; 2000; 20(2B):1121-4. PubMed ID: 10810406
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes.
Mourad WF; Shasha D; Blakaj DM; Khorsandi AS; Shourbaji RA; Glanzman J; Kabarriti R; Young R; Patel S; Katsoulakis E; Gámez M; Woode R; Lazarus C; Concert C; Hu KS; Harrison LB
Anticancer Res; 2013 Oct; 33(10):4483-9. PubMed ID: 24123019
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
39. Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer.
Verdonck-de Leeuw IM; Hilgers FJ; Keus RB; Koopmans-van Beinum FJ; Greven AJ; de Jong JM; Vreeburg G; Bartelink H
Laryngoscope; 1999 Feb; 109(2 Pt 1):241-8. PubMed ID: 10890774
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
